Sugi Predict

Sugi Predict / Compounds / SCHEMBL531007

SCHEMBL531007

SCHEMBL531007

O=C(CCCCC(=O)Oc1ccc([N+](=O)[O-])cc1)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL9 O00512 1/20 0.76
▸ CTNNB1 P35222 1/20 0.76
▸ TDP1 Q9NUW8 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ PTPN7 P35236 1/20 0.55
▸ PTPN12 Q05209 1/20 0.55
▸ PTPN22 Q9Y2R2 1/20 0.55
▸ KMT2A Q03164 4/20 0.54
▸ MGLL Q99685 2/20 0.54
▸ MAPT P10636 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ PKM P14618 1/20 0.51
▸ EGFR P00533 2/20 0.51
▸ ERBB2 P04626 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.48
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CES2 O00748 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570540 0.98 BCL9 (0.73) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL530771 0.98 BCL9 (0.73) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL531155 0.98 BCL9 (0.73) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL7079988 0.98 BCL9 (0.73) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL3919600 0.96 BCL9 (0.76) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL4746640 0.94 BCL9 (0.68) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL9657255 0.94 BCL9 (0.68) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL957930 0.93 BCL9 (0.81) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL1400174 0.92 BCL9 (0.80) BCL9CTNNB1TDP1GAAPTPN7
SCHEMBL531330 0.92 BCL9 (0.66) BCL9CTNNB1TDP1GAAPTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117942421-A Injectable multi-crosslinking double-network fiber/hydrogel wound dressing and preparation method thereof 上海工程技术大学 2024-04-30 — — CN claimed
CN-111068100-B Medical silk braided suture line and preparation method thereof 深圳市迈捷生命科学有限公司 2022-07-05 — — CN claimed
CN-111068100-A Medical silk braided suture line and preparation method thereof 刘科林 2020-04-28 — — CN claimed
US-20080193481-A1 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines GOVERNORS OF THE UNIVERSITY OF ALBERTA 2008-08-14 — — US claimed
EP-1863536-A1 SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES The Governors of the University of Alberta (CA) 2007-12-12 — — EP claimed
EP-1313794-B1 ELASTOMERIC FUNCTIONAL BIODEGRADABLE COPOLYESTER AMIDES AND COPOLYESTER URETHANES CORNELL RES FOUNDATION INC (US) 2006-11-29 — — EP claimed
WO-2006096970-A1 SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2006-09-21 — — WO claimed
US-20040063606-A1 Elastomeric functional biodegradable copolyester amides and copolyester urethanes CORNELL RESEARCH FOUNDATION, INC. 2004-04-01 — — US claimed
EP-1313794-A2 ELASTOMERIC FUNCTIONAL BIODEGRADABLE COPOLYESTER AMIDES AND COPOLYESTER URETHANES CORNELL RESEARCH FOUNDATION, INC. (US) 2003-05-28 — — EP claimed
US-6503538-B1 Elastomeric functional biodegradable copolyester amides and copolyester urethanes CORNELL RESEARCH FOUNDATION, INC. 2003-01-07 — — US claimed
WO-2002018477-A2 ELASTOMERIC FUNCTIONAL BIODEGRADABLE COPOLYESTER AMIDES AND COPOLYESTER URETHANES CORNELL RESEARCH FOUNDATION, INC. (US) 2002-03-07 — — WO claimed
EP-3474890-B1 PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION MAX PLANCK GESELLSCHAFT (DE) 2026-05-06 — — EP disclosed
EP-4729073-A1 SYNTHETIC VACCINES AGAINST FRANCISELLA TULARENSIS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2026-04-22 — — EP disclosed
EP-4682154-A1 PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF OLIGOSACCHARIDES REPRESENTING SEGMENTS OF O-ANTIGENS FROM DIVERSE SHIGELLA FLEXNERI SEROTYPES Institut Pasteur (FR) 2026-01-21 — — EP disclosed
WO-2025215228-A1 SYNTHETIC VACCINES AGAINST PORPHYROMONAS GINGIVALIS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-10-16 — — WO disclosed
WO-1994020881-A1 POLYMERS EXHIBITING NONLINEAR OPTICAL PROPERTIES ALLIEDSIGNAL INC. (US) 1994-09-15 — — WO disclosed
US-5328939-A Crosslinked nitrogen-containing polymers ALLIEDSIGNAL INC. (US) 1994-07-12 — — US disclosed
US-5322935-A Crosslinking chitosans with anionic salts followed by covalent crosslinkers; high strength, dimensional stability ALLIEDSIGNAL INC. (US) 1994-06-21 — — US disclosed
EP-0562624-A2 Stabilization of functional proteins Modrovich, Ivan E. (US) 1993-09-29 — — EP disclosed
US-5091527-A SUBSTRATE FOR PHOSPHOLIPASE BOEHRINGER MANNHEIM GMBH (DE) 1992-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193481-A1 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines DDOST, FUT5, STT3B BCL9 2213/4885CTNNB1 4704/4885TDP1 4018/4885
US-20040063606-A1 Elastomeric functional biodegradable copolyester amides and copolyester urethanes PUF60, UROD, UBE2I BCL9 4755/4885CTNNB1 4778/4885TDP1 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.